Helpful Links & Resources
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
Reading Time: 3 mins
Published On: September 14, 2024
Matthew Davis - author
Matthew Davis is a freelance journalist who has covered civil litigation for a variety of publications. He joined Mesowatch in 2016 and covers asbestos litigation developments in the U.S., as well as newsworthy asbestos cases.
More to Read
News & Data
FILTER:
J&J Raises Talcum Powder Settlement by Another $1.1 Billion
FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
J&J’s Talc Legal Battles: Medical Monitoring and Settlement
The Asbestos Lawsuit Process: From Diagnosis to Legal Action
Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
GAG-DP Biomaterial Advances Mesothelioma Research
$59.7M Transfer Triggers Legal Battle Over Asbestos Claims
Pleural and Peritoneal Mesothelioma Found in Female Patient
Study Finds State-Level Trends and Asbestos-Talc Risks
What The J&J $63.4M Talc Lung Cancer Verdict Means for You
The End of Asbestos: EPA’s Historic Ban and Its Implications
Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million
PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma
Secondary Exposure Emerges as a Hidden Threat in the Ongoing Asbestos Crisis
Avon’s Financial Turmoil: Chapter 11 Bankruptcy Amid Talc-Related Cancer Lawsuits
Browse Categories
Mesowatch's serves as an industry watchdog
and advocates for patients and families affected
by asbestos by providing reliable and up-to-date news
stories and information on asbestos and mesothelioma.
CONTACT US
Email: support@mesowatch.com
Phone: (866) 402-1000
Address: 3260 N Hayden Rd, Suite 210
Scottsdale, AZ 85251
Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.